Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers
Background: Data on the dynamics and persistence of humoral immunity against SARS-CoV-2 after primary vaccination with two-dose inactivated vaccine (CoronaVac) are limited. This study evaluated the sequential effects of prior infection, heterologous boosting with mRNA-1273 (Moderna), and the occurre...
Main Authors: | Suwarti, S, Lazarus, G, Zanjabila, S, Sinto, R, Fransiska, F, Deborah, T, Oktavia, D, Junaidah, J, Santayana, S, Surendra, H, Yuliana, J, Pardosi, H, Nuraeni, N, Soebianto, S, Susilowati, ND, Subekti, D, Pradipta, A, Baird, JK, Tan, LV, Dunachie, S, Shankar, AH, Nelwan, EJ, Hamers, RL |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BioMed Central
2024
|
Similar Items
-
Acute Myocarditis Following Vaccination With the First Dose of the mRNA-1273 Vaccine
by: Abdulbaril Olagunju MD, et al.
Published: (2022-04-01) -
Hypersensitivity reactions following the Moderna messenger RNA-1273 vaccine
by: Alex Drohan, MD, et al.
Published: (2021-10-01) -
Real-Time Survey of Vaccine Safety of the mRNA-1273 SARS-CoV-2 Vaccine in Workplace Vaccination at Keio University
by: Kaho Okumura, et al.
Published: (2022-09-01) -
Profiling antibody epitopes induced by mRNA-1273 vaccination and boosters
by: Bethany Girard, et al.
Published: (2024-03-01) -
Myasthenia Gravis Presenting after Administration of the mRNA-1273 Vaccine
by: Yoji Hoshina, et al.
Published: (2022-07-01)